Thomas Needham

Director/Board Member at RENOVACOR, INC.

62 year

Health Technology

Finance

Commercial Services

Profile

Mr. Thomas E.
Needham is a Chairman at Renovacor Holdings, Inc., an Independent Director at Renovacor, Inc., a Managing Director at LongView Ventures LLC, a Managing Director at Broadview Ventures Inc and a Chairman at Basking Biosciences, Inc. He is on the Board of Directors at Renovacor, Inc. Mr. Needham was previously employed as a Chief Business Officer by Merrimack Pharmaceuticals, Inc., a Senior Vice President-Business Development by C4 Therapeutics, Inc., a President & Director by Trident Pharmaceuticals, Inc., a Co-Founder by Synthesis Capital, a Principal by Advent International Corp, a Vice President by GPC Biotech AG, a Vice President by GPC Biotech, Inc., a Principal by ImmuLogic Pharmaceutical Corp., and a President, Chief Executive Officer & Director by Spear Therapeutics Ltd. He also served on the board at Prexa Pharmaceuticals, Inc. and Kantum Pharma, Inc. He received his undergraduate degree from Bowdoin College and an MBA from F.W.
Olin Graduate School of Business.

Thomas Needham active positions

Companies	Position	Start
RENOVACOR, INC.	Director/Board Member	01/08/2019
Basking Biosciences, Inc. Basking Biosciences, Inc. BiotechnologyHealth Technology Develops reversible thrombolytic therapy	Chairman	-
Renovacor Holdings, Inc. Renovacor Holdings, Inc. BiotechnologyHealth Technology Develops transformative gene therapy	Chairman	01/01/2020
Broadview Ventures, Inc. Broadview Ventures, Inc. Investment ManagersFinance Broadview Ventures invests in companies located across the globe, primarily in North America, Europe and Israel. The firm targets companies operating in the fields of healthcare and technology sectors. It provides financing for seed and early-stage capital requirements. The firm makes follow-on investments.	Private Equity Investor	01/03/2018
LongView Ventures LLC LongView Ventures LLC Investment ManagersFinance LongView Ventures invests in companies located in the United States. The firm focuses on the clinical-stage companies. It provides financing for early and later stage capital requirements.	Private Equity Investor	01/01/2019

All active positions of Thomas Needham

Former positions of Thomas Needham

Companies	Position	End
MERRIMACK PHARMACEUTICALS	Corporate Officer/Principal	01/03/2018
C4 THERAPEUTICS, INC.	Corporate Officer/Principal	01/06/2017
Advent International LP Advent International LP Investment ManagersFinance Advent invests in companies located across the globe. The firm targets companies operating in the fields of business & financial services, healthcare, industrial and technology services. It provides financing for leveraged buyout, recapitalizations, growth and public to private transactions. It also acquires majority and minority ownership.	Private Equity Investor	01/05/2007
GPC Biotech AG GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes new anticancer drugs	Corporate Officer/Principal	01/05/2003
░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░

See the detail of Thomas Needham's experience

Training of Thomas Needham

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Thomas Needham's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	18
Advent International LP Advent International LP Investment ManagersFinance Advent invests in companies located across the globe. The firm targets companies operating in the fields of business & financial services, healthcare, industrial and technology services. It provides financing for leveraged buyout, recapitalizations, growth and public to private transactions. It also acquires majority and minority ownership.	Finance
ImmuLogic Pharmaceutical Corp. ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Trident Pharmaceuticals, Inc. Trident Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel biologics for the treatment of autoimmune disorders	Health Technology
Prexa Pharmaceuticals, Inc. Prexa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral small molecule monoamine reuptake inhibitors	Health Technology
GPC Biotech AG GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes new anticancer drugs	Commercial Services
Merrimack Pharmaceuticals, Inc. Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer	Health Technology
GPC Biotech, Inc. GPC Biotech, Inc. Drugstore ChainsRetail Trade Develops anticancer drugs	Retail Trade
Bowdoin College Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Spear Therapeutics Ltd. Spear Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops cancer treatment drugs	Health Technology
Broadview Ventures, Inc. Broadview Ventures, Inc. Investment ManagersFinance Broadview Ventures invests in companies located across the globe, primarily in North America, Europe and Israel. The firm targets companies operating in the fields of healthcare and technology sectors. It provides financing for seed and early-stage capital requirements. The firm makes follow-on investments.	Finance
Synthesis Capital Synthesis Capital Investment ManagersFinance Synthesis Capital invests in US and European-based companies. The firm targets companies operating in the fields of bio-pharmaceutical and medical technology sectors. It provides financing for seed, early and late stage capital requirements.	Finance
F.W. Olin Graduate School of Business F.W. Olin Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
C4 Therapeutics, Inc. C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer	Health Technology
Kantum Pharma, Inc. Kantum Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel and receptor antagonist-based therapeutics for AKI diagnostic tests	Commercial Services
Renovacor Holdings, Inc. Renovacor Holdings, Inc. BiotechnologyHealth Technology Develops transformative gene therapy	Health Technology
LongView Ventures LLC LongView Ventures LLC Investment ManagersFinance LongView Ventures invests in companies located in the United States. The firm focuses on the clinical-stage companies. It provides financing for early and later stage capital requirements.	Finance
Basking Biosciences, Inc. Basking Biosciences, Inc. BiotechnologyHealth Technology Develops reversible thrombolytic therapy	Health Technology
Renovacor, Inc. Renovacor, Inc. BiotechnologyHealth Technology Engages in research and development for precision gene therapies and genetically driven cardiovascular diseases	Health Technology